Efecto del Triticum Vulgare intravaginal, en el tratamiento del síndrome genitourinario de la menopausia, en mujeres del Quindío, 2017-2019.

Autores:: Espitia De La Hoz, Franklin José

Tipo de recurso:: Article of journal

Fecha de publicación:: 2021

Institución:: Universidad de Cartagena

Repositorio:: Repositorio Universidad de Cartagena

Idioma:: spa

id	UCART2_05be18a4809c49ffa22c4db9bb426da5
oai_identifier_str	oai:repositorio.unicartagena.edu.co:11227/13490
network_acronym_str	UCART2
network_name_str	Repositorio Universidad de Cartagena
repository_id_str
dc.title.spa.fl_str_mv	Efecto del Triticum Vulgare intravaginal, en el tratamiento del síndrome genitourinario de la menopausia, en mujeres del Quindío, 2017-2019.
dc.title.translated.eng.fl_str_mv	Effect of intravaginal Triticum Vulgare, in the treatment of genitourinary syndrome of menopause, in women from Quindío, 2017-2019.
title	Efecto del Triticum Vulgare intravaginal, en el tratamiento del síndrome genitourinario de la menopausia, en mujeres del Quindío, 2017-2019.
spellingShingle	Efecto del Triticum Vulgare intravaginal, en el tratamiento del síndrome genitourinario de la menopausia, en mujeres del Quindío, 2017-2019. Postmenopause Efficacy Safety Drug therapy Atrophic vaginitis Posmenopausia Eficacia Seguridad Vaginitis Atrófica Tratamiento farmacológico Vaginitis atrófica
title_short	Efecto del Triticum Vulgare intravaginal, en el tratamiento del síndrome genitourinario de la menopausia, en mujeres del Quindío, 2017-2019.
title_full	Efecto del Triticum Vulgare intravaginal, en el tratamiento del síndrome genitourinario de la menopausia, en mujeres del Quindío, 2017-2019.
title_fullStr	Efecto del Triticum Vulgare intravaginal, en el tratamiento del síndrome genitourinario de la menopausia, en mujeres del Quindío, 2017-2019.
title_full_unstemmed	Efecto del Triticum Vulgare intravaginal, en el tratamiento del síndrome genitourinario de la menopausia, en mujeres del Quindío, 2017-2019.
title_sort	Efecto del Triticum Vulgare intravaginal, en el tratamiento del síndrome genitourinario de la menopausia, en mujeres del Quindío, 2017-2019.
dc.creator.fl_str_mv	Espitia De La Hoz, Franklin José
dc.contributor.author.spa.fl_str_mv	Espitia De La Hoz, Franklin José
dc.subject.eng.fl_str_mv	Postmenopause Efficacy Safety Drug therapy Atrophic vaginitis
topic	Postmenopause Efficacy Safety Drug therapy Atrophic vaginitis Posmenopausia Eficacia Seguridad Vaginitis Atrófica Tratamiento farmacológico Vaginitis atrófica
dc.subject.spa.fl_str_mv	Posmenopausia Eficacia Seguridad Vaginitis Atrófica Tratamiento farmacológico Vaginitis atrófica
publishDate	2021
dc.date.accessioned.none.fl_str_mv	2021-07-15 00:00:00
dc.date.available.none.fl_str_mv	2021-07-15 00:00:00
dc.date.issued.none.fl_str_mv	2021-07-15
dc.type.spa.fl_str_mv	Artículo de revista
dc.type.coar.fl_str_mv	http://purl.org/coar/resource_type/c_2df8fbb1
dc.type.version.spa.fl_str_mv	info:eu-repo/semantics/publishedVersion
dc.type.coarversion.spa.fl_str_mv	http://purl.org/coar/version/c_970fb48d4fbd8a85
dc.type.coar.spa.fl_str_mv	http://purl.org/coar/resource_type/c_6501
dc.type.content.spa.fl_str_mv	Text
dc.type.driver.spa.fl_str_mv	info:eu-repo/semantics/article
dc.type.local.eng.fl_str_mv	Journal article
dc.type.redcol.spa.fl_str_mv	http://purl.org/redcol/resource_type/ART
format	http://purl.org/coar/resource_type/c_6501
status_str	publishedVersion
dc.identifier.issn.none.fl_str_mv	2215-7840
dc.identifier.doi.none.fl_str_mv	10.32997/rcb-2021-3497
dc.identifier.eissn.none.fl_str_mv	2389-7252
dc.identifier.url.none.fl_str_mv	https://doi.org/10.32997/rcb-2021-3497
identifier_str_mv	2215-7840 10.32997/rcb-2021-3497 2389-7252
url	https://doi.org/10.32997/rcb-2021-3497
dc.language.iso.spa.fl_str_mv	spa
language	spa
dc.relation.ispartofjournal.spa.fl_str_mv	Revista Ciencias Biomédicas
dc.relation.bitstream.none.fl_str_mv	https://revistas.unicartagena.edu.co/index.php/cbiomedicas/article/download/3497/2942
dc.relation.citationedition.spa.fl_str_mv	Núm. 3 , Año 2021
dc.relation.citationendpage.none.fl_str_mv	162
dc.relation.citationissue.spa.fl_str_mv	3
dc.relation.citationstartpage.none.fl_str_mv	152
dc.relation.citationvolume.spa.fl_str_mv	10
dc.relation.references.spa.fl_str_mv	The North American Menopause Society (NAMS). The 2020 genitourinary syndrome of menopause position statement of The North American Menopause Society. Menopause. 2020; 27(9): 976-92. https://doi.org/10.1097/GME.0000000000001609 Espitia De La Hoz FJ. Prevalence of genitourinary syndrome of menopause and impact on sexuality of women in Quindío (Colombia), 2013-2016. Rev Colomb Obstet Ginecol 2018; 69(4): 249-59. https://doi.org/10.18597/rcog.3111 Gandhi J, Chen A, Dagur G, Suh Y, Smith N, Cali B, Khan SA. Genitourinary syndrome of menopause: an overview of clinical manifestations, pathophysiology, etiology, evaluation, and management. Am J Obstet Gynecol. 2016; 215(6): 704-11. https://doi.org/10.1016/j.ajog.2016.07.045 Krychman M, Graham S, Bernick B, Mirkin S, Kingsberg SA. The Women's EMPOWER Survey: Women's Knowledge and Awareness of Treatment Options for Vulvar and Vaginal Atrophy Remains Inadequate. J Sex Med. 2017; 14(3): 425-433. https://doi.org/10.1016/j.jsxm.2017.01.011 Moral E, Delgado JL, Carmona F, Caballero B, Guillán C, González PM, Suárez-Almarza J, Velasco-Ortega S, Nieto C; as the writing group of the GENISSE study. Genitourinary syndrome of menopause. Prevalence and quality of life in Spanish postmenopausal women. The GENISSE study. Climacteric. 2018; 21(2): 167-73. https://doi.org/10.1080/13697137.2017.1421921 Palma F, Xholli A, Cagnacci A; as the writing group of the AGATA study. The most bothersome symptom of vaginal atrophy: Evidence from the observational AGATA study. Maturitas. 2018; 108: 18-23. https://doi.org/10.1016/j.maturitas.2017.11.007 Portman DJ, Gass ML; Vulvovaginal Atrophy Terminology Consensus Conference Panel. Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women's Sexual Health and the North American Menopause Society. Menopause. 2014; 21(10): 1063-8. https://doi.org/10.1097/GME.0000000000000329 Simon JA, Nappi RE, Kingsberg SA, Maamari R, Brown V . Clarifying V aginal Atrophy's Impact on Sex and Relationships (CLOSER) survey: emotional and physical impact of vaginal discomfort on North American postmenopausal women and their partners. Menopause. 2014; 21(2): 137-42. https://doi.org/10.1097/GME.0b013e318295236f Kingsberg SA, Wysocki S, Magnus L, Krychman ML. Vulvar and vaginal atrophy in postmenopausal women: findings from the REVIVE (REal Women's VIews of Treatment Options for Menopausal Vaginal ChangEs) survey. J Sex Med. 2013; 10(7): 1790-9. https://doi.org/10.1111/jsm.12190 Cumming GP, Herald J, Moncur R, Currie H, Lee AJ. Women's attitudes to hormone replacement therapy, alternative therapy and sexual health: a web-based survey. Menopause Int. 2007; 13(2): 79-83. https://doi.org/10.1258/175404507780796424 Espitia De La Hoz FJ, Orozco Gallego H. Estriol vs estrógenos conjugados de origen equino en el tratamiento del síndrome genitourinario de la menopausia. Ginecol Obstet Mex 2018; 86(2): 117-26. https://doi.org/10.24245/gom.v86i2.1881 North American Menopause Society. The role of local vaginal estrogen for treatment of vaginal atrophy in postmenopausal women: 2007 position statement of The North American Menopause Society. Menopause. 2007; 14(3 Pt 1): 355-69; quiz 370-1. https://doi.org/10.1097/gme.0b013e31805170eb Martini P, Mazzatenta C, Saponati G. Efficacy and tolerability of fitostimoline in two different forms (soaked gauzes and cream) and citrizan gel in the topical treatment of second-degree superficial cutaneous burns. Dermatol Res Pract. 2011; 2011: 978291. https://doi.org/10.1155/2011/978291 Romanelli M, Macchia M, Panduri S, Paggi B, Saponati G, Dini V. Clinical evaluation of the efficacy and safety of a medical device in various forms containing Triticum vulgare for the treatment of venous leg ulcers - a randomized pilot study. Drug Des Devel Ther. 2015; 27(9): 2787-92. https://doi.org/10.2147/DDDT.S82712 Mollica G, Bonaccorsi G, Martinello R, Minale DG. Evaluation of efficacy and tolerability of fitostimoline vaginal cream (Damor farmaceutici) in the treatment of vaginal inflammation and vulvar dystrophy: A double- blind randomized controlled trial. Gazz. Med. Ital. Arch. Per. Le Sci. Med. 2008; 167(3): 87–95. Espitia De La Hoz FJ. Efectividad y seguridad del policresuleno en el tratamiento del síndrome genitourinario de la menopausia. Estudio controlado y aleatorizado. Arch Med (Manizales). 2020; 20(2): 282- 94. https://doi.org/10.30554/archmed.20.2.3743.2020 Rosen R, Brown C, Heiman J, Leiblum S, Meston C, Shabsigh R, Ferguson D, D'Agostino R Jr. The Female Sexual Function Index (FSFI): a multidimensional self- report instrument for the assessment of female sexual function. J Sex Marital Ther. 2000; 26(2): 191-208. https://doi.org/10.1080/009262300278597 Dall'Agno ML, Ferreira CF, Ferreira FV, Pérez-López FR, Wender MCO. Validation of the Six-item Female Sexual Function Index in Middle-Aged Brazilian Women. Rev Bras Ginecol Obstet. 2019; 41(7): 432-439. https://doi.org/10.1055/s-0039-1692694 Espitia De La Hoz FJ. Prevalence and characterization of sexual dysfunctions in women, in 12 Colombian cities, 2009-2016. Rev Colomb Obstet Ginecol. 2018; 69(1):9- 21. https://doi.org/10.18597/rcog.3035 Kingsberg SA, Krychman ML. Resistance and barriers to local estrogen therapy in women with atrophic vaginitis. J Sex Med. 2013; 10(6): 1567-74. https://doi.org/10.1111/jsm.12120 Espitia De la Hoz FJ, Orozco Gallego H. Abordaje diagnóstico y terapéutico del síndrome genitourinario en la menopausia; actualización. Rev Med UCR 2017; 11(2): 67-84. https://doi.org/10.15517/rmucr.v11i2.34580 Arunkalaivanan A, Kaur H, Onuma O. Laser therapy as a treatment modality for genitourinary syndrome of menopause: a critical appraisal of evidence. Int Urogynecol J. 2017; 28(5): 681–5. https://doi.org/10.1007/s00192-017-3282-y Rabley A, O’Shea T, Terry R, Byun S, Louis Moy M. Laser therapy for genitourinary syndrome of menopause. Curr Urol Rep. 2018; 19(10): 83. https://doi.org/10.1007/s11934-018-0831-y D’Antona N, Ricci MG et al. The use of vaginal cream fitostimoline in the therapy of vulvovaginitis and as coadjuvant treatment of diathermocoagulation (DTC) of the portio. Rass Int Clin Ter 1989; 69(19): 873-83. De Punzio C, Bagnoni G, et al. Efficacia del Triticum vulgare nel trattamento post-menopausale della mucosa vaginale. Aggio Sci Ginecol Ostetr 1991; 6:1-4. Santoro MG, Lavazzi B, et al. Trattamento delle vulvovaginiti con fitostimoline: primi risultati. Estratto da V Convergno Nazionale della Societa Italiana di Colposcopia e Patologia Cervico-vaginale, Rimini, 25-27 maggio, 1989. Trapani A, Castobello C, et al. Treatment of cervico- vaginal dystrophies with vaginal suppositories of Triticum vulgare and glycolethilen-monophenolic ether. Medicina Oggi 1987; 3(1): 21. Boselli F, Petrella E, Campedelli A, Muzi M, Rullo V, Ascione L, Papa R, Saponati G. Efficacy and tolerability of fitostimoline (vaginal cream, ovules, and vaginal washing) and of benzydamine hydrochloride (tantum rosa vaginal cream and vaginal washing) in the topical treatment of symptoms of bacterial vaginosis. ISRN Obstet Gynecol. 2012; 2012: 183403. https://doi.org/10.5402/2012/183403 Levy P, Coriolano A, et al. A clinical evaluation of a new vaginal cream after cervical coagulation. J Bras Ginec 1983; 93(6): 339-44. Espitia-de-la-Hoz FJ. Tratamiento no hormonal del síndrome genitourinario de la menoapusia. Arch Med (Manizales) 2021. 21(2): en prensa. https://doi.org/10.30554/archmed.21.2.3996.2021
dc.rights.spa.fl_str_mv	Franklin José Espitia De La Hoz - 2021
dc.rights.uri.spa.fl_str_mv	https://creativecommons.org/licenses/by-nc-sa/4.0
dc.rights.coar.spa.fl_str_mv	http://purl.org/coar/access_right/c_abf2
dc.rights.accessrights.spa.fl_str_mv	info:eu-repo/semantics/openAccess
rights_invalid_str_mv	Franklin José Espitia De La Hoz - 2021 https://creativecommons.org/licenses/by-nc-sa/4.0 http://purl.org/coar/access_right/c_abf2
eu_rights_str_mv	openAccess
dc.format.mimetype.spa.fl_str_mv	application/pdf
dc.publisher.spa.fl_str_mv	Universidad de Cartagena
dc.source.spa.fl_str_mv	https://revistas.unicartagena.edu.co/index.php/cbiomedicas/article/view/3497
institution	Universidad de Cartagena
bitstream.url.fl_str_mv	https://repositorio.unicartagena.edu.co/bitstreams/31cd97b3-91a5-416c-97e4-bc4184e6818f/download
bitstream.checksum.fl_str_mv	4a694300ff61e7f537c2c722a5fd800d
bitstream.checksumAlgorithm.fl_str_mv	MD5
repository.name.fl_str_mv	Biblioteca Digital Universidad de Cartagena
repository.mail.fl_str_mv	bdigital@metabiblioteca.com
_version_	1814214010745126912
spelling	Espitia De La Hoz, Franklin José2021-07-15 00:00:002021-07-15 00:00:002021-07-152215-784010.32997/rcb-2021-34972389-7252https://doi.org/10.32997/rcb-2021-3497application/pdfspaUniversidad de CartagenaRevista Ciencias Biomédicashttps://revistas.unicartagena.edu.co/index.php/cbiomedicas/article/download/3497/2942Núm. 3 , Año 2021162315210The North American Menopause Society (NAMS). The 2020 genitourinary syndrome of menopause position statement of The North American Menopause Society. Menopause. 2020; 27(9): 976-92. https://doi.org/10.1097/GME.0000000000001609Espitia De La Hoz FJ. Prevalence of genitourinary syndrome of menopause and impact on sexuality of women in Quindío (Colombia), 2013-2016. Rev Colomb Obstet Ginecol 2018; 69(4): 249-59. https://doi.org/10.18597/rcog.3111Gandhi J, Chen A, Dagur G, Suh Y, Smith N, Cali B, Khan SA. Genitourinary syndrome of menopause: an overview of clinical manifestations, pathophysiology, etiology, evaluation, and management. Am J Obstet Gynecol. 2016; 215(6): 704-11. https://doi.org/10.1016/j.ajog.2016.07.045Krychman M, Graham S, Bernick B, Mirkin S, Kingsberg SA. The Women's EMPOWER Survey: Women's Knowledge and Awareness of Treatment Options for Vulvar and Vaginal Atrophy Remains Inadequate. J Sex Med. 2017; 14(3): 425-433. https://doi.org/10.1016/j.jsxm.2017.01.011Moral E, Delgado JL, Carmona F, Caballero B, Guillán C, González PM, Suárez-Almarza J, Velasco-Ortega S, Nieto C; as the writing group of the GENISSE study. Genitourinary syndrome of menopause. Prevalence and quality of life in Spanish postmenopausal women. The GENISSE study. Climacteric. 2018; 21(2): 167-73. https://doi.org/10.1080/13697137.2017.1421921Palma F, Xholli A, Cagnacci A; as the writing group of the AGATA study. The most bothersome symptom of vaginal atrophy: Evidence from the observational AGATA study. Maturitas. 2018; 108: 18-23. https://doi.org/10.1016/j.maturitas.2017.11.007Portman DJ, Gass ML; Vulvovaginal Atrophy Terminology Consensus Conference Panel. Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women's Sexual Health and the North American Menopause Society. Menopause. 2014; 21(10): 1063-8. https://doi.org/10.1097/GME.0000000000000329Simon JA, Nappi RE, Kingsberg SA, Maamari R, Brown V . Clarifying V aginal Atrophy's Impact on Sex and Relationships (CLOSER) survey: emotional and physical impact of vaginal discomfort on North American postmenopausal women and their partners. Menopause. 2014; 21(2): 137-42. https://doi.org/10.1097/GME.0b013e318295236fKingsberg SA, Wysocki S, Magnus L, Krychman ML. Vulvar and vaginal atrophy in postmenopausal women: findings from the REVIVE (REal Women's VIews of Treatment Options for Menopausal Vaginal ChangEs) survey. J Sex Med. 2013; 10(7): 1790-9. https://doi.org/10.1111/jsm.12190Cumming GP, Herald J, Moncur R, Currie H, Lee AJ. Women's attitudes to hormone replacement therapy, alternative therapy and sexual health: a web-based survey. Menopause Int. 2007; 13(2): 79-83. https://doi.org/10.1258/175404507780796424Espitia De La Hoz FJ, Orozco Gallego H. Estriol vs estrógenos conjugados de origen equino en el tratamiento del síndrome genitourinario de la menopausia. Ginecol Obstet Mex 2018; 86(2): 117-26. https://doi.org/10.24245/gom.v86i2.1881North American Menopause Society. The role of local vaginal estrogen for treatment of vaginal atrophy in postmenopausal women: 2007 position statement of The North American Menopause Society. Menopause. 2007; 14(3 Pt 1): 355-69; quiz 370-1. https://doi.org/10.1097/gme.0b013e31805170ebMartini P, Mazzatenta C, Saponati G. Efficacy and tolerability of fitostimoline in two different forms (soaked gauzes and cream) and citrizan gel in the topical treatment of second-degree superficial cutaneous burns. Dermatol Res Pract. 2011; 2011: 978291. https://doi.org/10.1155/2011/978291Romanelli M, Macchia M, Panduri S, Paggi B, Saponati G, Dini V. Clinical evaluation of the efficacy and safety of a medical device in various forms containing Triticum vulgare for the treatment of venous leg ulcers - a randomized pilot study. Drug Des Devel Ther. 2015; 27(9): 2787-92. https://doi.org/10.2147/DDDT.S82712Mollica G, Bonaccorsi G, Martinello R, Minale DG. Evaluation of efficacy and tolerability of fitostimoline vaginal cream (Damor farmaceutici) in the treatment of vaginal inflammation and vulvar dystrophy: A double- blind randomized controlled trial. Gazz. Med. Ital. Arch. Per. Le Sci. Med. 2008; 167(3): 87–95.Espitia De La Hoz FJ. Efectividad y seguridad del policresuleno en el tratamiento del síndrome genitourinario de la menopausia. Estudio controlado y aleatorizado. Arch Med (Manizales). 2020; 20(2): 282- 94. https://doi.org/10.30554/archmed.20.2.3743.2020Rosen R, Brown C, Heiman J, Leiblum S, Meston C, Shabsigh R, Ferguson D, D'Agostino R Jr. The Female Sexual Function Index (FSFI): a multidimensional self- report instrument for the assessment of female sexual function. J Sex Marital Ther. 2000; 26(2): 191-208. https://doi.org/10.1080/009262300278597Dall'Agno ML, Ferreira CF, Ferreira FV, Pérez-López FR, Wender MCO. Validation of the Six-item Female Sexual Function Index in Middle-Aged Brazilian Women. Rev Bras Ginecol Obstet. 2019; 41(7): 432-439. https://doi.org/10.1055/s-0039-1692694Espitia De La Hoz FJ. Prevalence and characterization of sexual dysfunctions in women, in 12 Colombian cities, 2009-2016. Rev Colomb Obstet Ginecol. 2018; 69(1):9- 21. https://doi.org/10.18597/rcog.3035Kingsberg SA, Krychman ML. Resistance and barriers to local estrogen therapy in women with atrophic vaginitis. J Sex Med. 2013; 10(6): 1567-74. https://doi.org/10.1111/jsm.12120Espitia De la Hoz FJ, Orozco Gallego H. Abordaje diagnóstico y terapéutico del síndrome genitourinario en la menopausia; actualización. Rev Med UCR 2017; 11(2): 67-84. https://doi.org/10.15517/rmucr.v11i2.34580Arunkalaivanan A, Kaur H, Onuma O. Laser therapy as a treatment modality for genitourinary syndrome of menopause: a critical appraisal of evidence. Int Urogynecol J. 2017; 28(5): 681–5. https://doi.org/10.1007/s00192-017-3282-yRabley A, O’Shea T, Terry R, Byun S, Louis Moy M. Laser therapy for genitourinary syndrome of menopause. Curr Urol Rep. 2018; 19(10): 83. https://doi.org/10.1007/s11934-018-0831-yD’Antona N, Ricci MG et al. The use of vaginal cream fitostimoline in the therapy of vulvovaginitis and as coadjuvant treatment of diathermocoagulation (DTC) of the portio. Rass Int Clin Ter 1989; 69(19): 873-83.De Punzio C, Bagnoni G, et al. Efficacia del Triticum vulgare nel trattamento post-menopausale della mucosa vaginale. Aggio Sci Ginecol Ostetr 1991; 6:1-4.Santoro MG, Lavazzi B, et al. Trattamento delle vulvovaginiti con fitostimoline: primi risultati. Estratto da V Convergno Nazionale della Societa Italiana di Colposcopia e Patologia Cervico-vaginale, Rimini, 25-27 maggio, 1989.Trapani A, Castobello C, et al. Treatment of cervico- vaginal dystrophies with vaginal suppositories of Triticum vulgare and glycolethilen-monophenolic ether. Medicina Oggi 1987; 3(1): 21.Boselli F, Petrella E, Campedelli A, Muzi M, Rullo V, Ascione L, Papa R, Saponati G. Efficacy and tolerability of fitostimoline (vaginal cream, ovules, and vaginal washing) and of benzydamine hydrochloride (tantum rosa vaginal cream and vaginal washing) in the topical treatment of symptoms of bacterial vaginosis. ISRN Obstet Gynecol. 2012; 2012: 183403. https://doi.org/10.5402/2012/183403Levy P, Coriolano A, et al. A clinical evaluation of a new vaginal cream after cervical coagulation. J Bras Ginec 1983; 93(6): 339-44.Espitia-de-la-Hoz FJ. Tratamiento no hormonal del síndrome genitourinario de la menoapusia. Arch Med (Manizales) 2021. 21(2): en prensa. https://doi.org/10.30554/archmed.21.2.3996.2021Franklin José Espitia De La Hoz - 2021https://creativecommons.org/licenses/by-nc-sa/4.0http://purl.org/coar/access_right/c_abf2info:eu-repo/semantics/openAccessEsta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-CompartirIgual 4.0.https://revistas.unicartagena.edu.co/index.php/cbiomedicas/article/view/3497PostmenopauseEfficacySafetyDrug therapyAtrophic vaginitisPosmenopausiaEficaciaSeguridadVaginitis AtróficaTratamiento farmacológicoVaginitis atróficaEfecto del Triticum Vulgare intravaginal, en el tratamiento del síndrome genitourinario de la menopausia, en mujeres del Quindío, 2017-2019.Effect of intravaginal Triticum Vulgare, in the treatment of genitourinary syndrome of menopause, in women from Quindío, 2017-2019.Artículo de revistainfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/version/c_970fb48d4fbd8a85http://purl.org/coar/resource_type/c_6501http://purl.org/coar/resource_type/c_2df8fbb1Textinfo:eu-repo/semantics/articleJournal articlehttp://purl.org/redcol/resource_type/ARTPublicationOREORE.xmltext/xml2678https://repositorio.unicartagena.edu.co/bitstreams/31cd97b3-91a5-416c-97e4-bc4184e6818f/download4a694300ff61e7f537c2c722a5fd800dMD5111227/13490oai:repositorio.unicartagena.edu.co:11227/134902024-09-05 15:30:25.194https://creativecommons.org/licenses/by-nc-sa/4.0Franklin José Espitia De La Hoz - 2021metadata.onlyhttps://repositorio.unicartagena.edu.coBiblioteca Digital Universidad de Cartagenabdigital@metabiblioteca.com

Efecto del Triticum Vulgare intravaginal, en el tratamiento del síndrome genitourinario de la menopausia, en mujeres del Quindío, 2017-2019.

Publicaciones similares